These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Radioiodine therapy and thyrostatic drugs and iodine. Moka D; Dietlein M; Schicha H Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550 [TBL] [Abstract][Full Text] [Related]
9. [Reduction of thyroid volume following radioiodine therapy for functional autonomy]. Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274 [TBL] [Abstract][Full Text] [Related]
10. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine. Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711 [TBL] [Abstract][Full Text] [Related]
11. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes]. Wellner U; Eschner W; Hillger HW; Schicha H Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232 [TBL] [Abstract][Full Text] [Related]
13. The effect of carbimazole following radioiodine therapy on radiation dose to the thyroid. Gimlette TM; Kocak R; Herbert RG; Squire CR Nuklearmedizin; 1981 Apr; 20(2):72-5. PubMed ID: 6165965 [TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy for thyroid volume reduction of large goitres. Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116 [TBL] [Abstract][Full Text] [Related]
15. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents]. Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933 [TBL] [Abstract][Full Text] [Related]
16. Improvement of iodine deficiency after iodine supplementation in schoolchildren of Azerbaijan was accompanied by hypo and hyperthyrotropinemia and increased title of thyroid autoantibodies. Markou KB; Georgopoulos NA; Makri M; Vlasopoulou B; Anastasiou E; Vagenakis GA; Kouloubi K; Theodosopoulos N; Lazarou N; Veizis A; Sakellaropoulos G; Vagenakis AG J Endocrinol Invest; 2003; 26(2 Suppl):43-8. PubMed ID: 12762640 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment]. Véliz J; Pineda G; Arancibia P; Wohllk N Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059 [TBL] [Abstract][Full Text] [Related]
19. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259 [TBL] [Abstract][Full Text] [Related]
20. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease. Baczyk M; Junik R; Ziemnicka K; Sowiński J Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]